Download the 2011 Conference Brochure - UBM Canon Events
Download the 2011 Conference Brochure - UBM Canon Events
Download the 2011 Conference Brochure - UBM Canon Events
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Sponsored by:<br />
23–24 FEBRUARY <strong>2011</strong> • GRANDE HALLE DE LA VILLETTE, PARIS<br />
2 ND EDITION<br />
A European Congress for Developing New Drug Delivery<br />
Systems and Novel Therapeutic Devices<br />
<strong>Conference</strong> Programme<br />
Co-located with:<br />
www.biomedevice-europe.com<br />
Over 20 international speakers delivering regulatory updates,<br />
<strong>the</strong> latest innovations for drug/biologic delivery systems and<br />
biomedical devices, including:<br />
• Regulatory Updates for Combination Products in Europe<br />
and in USA: Status, Lessons and Future Vision – In View<br />
of Competent Authorities and Notified Bodies<br />
• Combination Products Today and in Future: Drugs and<br />
Biologicals - New Delivery Systems<br />
• Enabling Technologies for Combination Product Design<br />
and Development<br />
www.pharmapack.fr<br />
Next
BIOMEDEVICE EUROPE <strong>2011</strong> CONFERENCE PROGRAMME<br />
23–24 FEBRUARY <strong>2011</strong> PARIS, FRANCE • GRANDE HALLE DE LA VILLETTE<br />
DAY 1 – WEDNESDAY 23 FEBRUARY <strong>2011</strong><br />
SESSION 1 Regulatory Update for Combination Products in Europe and in USA:<br />
Status, Lessons and Future Vision<br />
Moderator:<br />
Dr. Yves Th. Tillet, CEO, WHITE-TILLET Consultants & Experts<br />
Faraj Abdelnour, President of ACIDIM, Senior Consultant Europe, Quintiles Consulting<br />
9.30–12.00 • Keynotes from Competent Authorities<br />
S1-1 Opening Address<br />
Dr. Yves Th. Tillet, CEO, WHITE-TILLET Consultants & Experts<br />
S1-2 Regulatory update in France<br />
Stephane Palies, Head of Innovation, AFSSAPS<br />
10.20–10.40 Coffee break, visit <strong>the</strong> exhibition<br />
S1-3 Regulatory update in <strong>the</strong> UK<br />
Elizabeth Baker, Group Manager Licensing, MHRA<br />
S1-4 Regulatory update in <strong>the</strong> USA<br />
Jill Hartzler Warner, J. D., Acting Associate Commissioner for Special Medical Programs, US FDA<br />
11.40 • Discussion Panel<br />
12.00 Networking lunch in <strong>the</strong> exhibition area<br />
13.45–15.00 • Keynotes from Notified Bodies<br />
S1-5 Experience from French Notified Body<br />
Dr. Thierry Thomas, Head of Certification G-MED, LNE<br />
S1-6 Experience from British Notified Body<br />
Theresa Jeary, Certification Manager, BSI Healthcare<br />
S1-7 Experience from German Notified Body<br />
Dr. Wilma Hartung, General Manager Medical/Business Division Products,<br />
TÜV Rheinland LGA Products GmbH<br />
15.00 Coffee break, visit <strong>the</strong> exhibition<br />
15.15–16.30 SESSION 2 Roundtable: Exchanges Between Industrial Representatives,<br />
Contract R&D Organisations and <strong>the</strong> Day’s Speakers<br />
Moderator:<br />
Faraj Abdelnour, President of ACIDIM, Senior Consultant Europe, Quintiles Consulting<br />
Dr. Yves Th. Tillet, CEO, WHITE-TILLET Consultants & Experts<br />
S2-1 Case study from a pharmaceutical company (10’)<br />
Speaker TBC<br />
S2-2 Case study from a pharmaceutical company (10’)<br />
Speaker TBC<br />
S2-3 Experience from a contract R&D organisation (10’)<br />
Prof. Dr. Markus Veit, CEO, i.DRAS GmbH<br />
15.50 • Discussion Panel<br />
Faraj Abdelnour, (ACIDIM, Quintiles)<br />
Dr. Yves Th. Tillet, (WHITE-TILLET Consultants & Experts)<br />
Stephane Palies, (AFSSAPS)<br />
Elizabeth Baker, (MHRA)<br />
16.30 • <strong>Conference</strong> Closes<br />
Dr. Thierry Thomas, (LNE G-Med)<br />
Theresa Jeary, (BSI Healthcare)<br />
Dr. Wilma Hartung, (TÜV Rheinland LGA Products GmbH)<br />
Back Next
DAY 2 – THURSDAY 24 FEBRUARY <strong>2011</strong><br />
9.30–12.00 SESSION 3 Combination Products Today and in <strong>the</strong> Future:<br />
Drugs and Biologicals - New Delivery Systems<br />
Moderator:<br />
Frank Richter, Head of Quality & Risk Management for Medical Devices, Sanofi-Aventis Deutschland GmbH<br />
Prof. Dr. Markus Veit, CEO, i.DRAS GmbH<br />
S3-1 Commercialising drug device combination products - Future perspectives<br />
Crispin Simon, CEO, Biocompatibles UK Ltd<br />
S3-2 Overview of injectable drug devices for self-administration including pens,<br />
auto-injectors and new patch-injector/pump devices<br />
Ian Thompson, Head of Business Development, Delivery Systems, Ypsomed AG<br />
S3-3 Recent advances in transdermal delivery of biologics<br />
Steven P. Damon, Senior Vice President, Business Development, Altea Therapeutics<br />
10.55–11.10 Coffee break, visit <strong>the</strong> exhibition<br />
S3-4 Targeted drug delivery to <strong>the</strong> central nervous system (brain and spinal cord)<br />
Prof. K. K. Jain, M.D., CEO, Jain PharmaBiotech<br />
S3-5 Combination of diagnostics and <strong>the</strong>rapeutics<br />
Prof. K. K. Jain, M.D., CEO, Jain PharmaBiotech<br />
12.00 Networking lunch in <strong>the</strong> exhibition area<br />
www.biomedevice-europe.com<br />
13.30–16.10 SESSION 4 Enabling Technologies for Combination Product Design and Development<br />
Moderator:<br />
Prof. Frederic Hildebrand, Research Director, Biomaterial Research Group, Inserm Lille, France<br />
Crispin Simon, CEO, Biocompatibles UK Ltd, UK<br />
S4-1 Significance of multi-responsive microgels for biomedical applications<br />
Muhammad Zafar, Research Scholar, University of Bolton, UK<br />
S4-2 A bioabsorbable product, providing <strong>the</strong> controlled release of local anes<strong>the</strong>tics<br />
to minimize postoperative pain<br />
Dr. Edouard Pelissier, Scientific Advisor, Statice Santé<br />
S4-3 Biomedical textiles in implantable medical devices<br />
Jeffrey M. Koslosky, Director of Technology & Product Development, Secant Medical LLC<br />
S4-4 Peritoneal implants with controlled release of <strong>the</strong>rapeutic molecules<br />
Nicolas Blanchemain, Assistant professor, Biomaterial Research Unity, Inserm Lille<br />
S4-5 Bioceramics as drug carriers for controlled-release technology<br />
Dr. Xiang Zhang, Principal Consultant, Medical Materials/Devices, CERAM, UK<br />
S4-6 Cost-effective nano-coating protection of medical devices (protein resistance,<br />
anti-microbial)<br />
Dr. Delwyn Evans, Principal Chemist, P2i, UK<br />
16.10 • <strong>Conference</strong> Closes<br />
For more details about <strong>the</strong> conference programme<br />
or to register, please visit<br />
www.biomedevice-europe.com<br />
Back Next
www.biomedevice-europe.com<br />
<strong>Conference</strong> registration includes admission to all sessions on registered<br />
day(s); visitor admission to <strong>the</strong> exhibition hall, coffee breaks and luncheon<br />
each day; magazines and <strong>the</strong> exhibition guide.<br />
Cancellation requests must be sent in writing before 4 February <strong>2011</strong>,<br />
after which attendance fees will be payable in full. However, substitutes<br />
may replace attendees upon request.<br />
Hotel and Transportation<br />
For information about hotels and transportation, please visit <strong>the</strong><br />
information page on our website:<br />
www.biomedevice-europe.com<br />
Enquiries<br />
If you have any questions about <strong>the</strong> conference or how to register,<br />
please do not hesitate to contact us:<br />
Tel: +33 (0)1 77 48 10 04<br />
The Organisers<br />
A World Leader in Medical Device Communications<br />
<strong>Conference</strong> Language<br />
The official conference language is English.<br />
Programme Alterations<br />
It may be necessary, for reasons beyond <strong>the</strong> control of <strong>the</strong> organisers,<br />
to alter <strong>the</strong> content and timing of <strong>the</strong> programme of <strong>the</strong> speakers.<br />
Data Protection<br />
<strong>UBM</strong> <strong>Canon</strong>, <strong>the</strong> leading B-to-B media company dedicated exclusively to <strong>the</strong><br />
global $3 trillion advanced manufacturing sector, helps support <strong>the</strong> flow of<br />
information, commerce and innovation in such sophisticated segments as<br />
medical devices and pharmaceutical development. <strong>UBM</strong> <strong>Canon</strong> also addresses<br />
cutting-edge developments in broader areas of advanced engineering<br />
design and manufacturing, and manufacturing processes and packaging.<br />
<strong>UBM</strong> <strong>Canon</strong>’s portfolio of events for <strong>the</strong> healthcare manufacturing<br />
sectors includes MEDTEC, MD&M, BIOMEDevice, and Pharmapack.<br />
<strong>UBM</strong> <strong>Canon</strong> also publishes a multitude of industry magazines, including<br />
European Medical Device Technology, China Medical Device Manufacturer,<br />
Japan Medical Design and Manufacturing Technology, Medical Device<br />
and Diagnostic Industry and Medical Product Manufacturing News.<br />
With this unique media portfolio, <strong>UBM</strong> <strong>Canon</strong> is able to connect<br />
over 3,500 medical-device industry suppliers with more than<br />
100,000 design and manufacturing professionals every year.<br />
The information you provide will be held on a database for our own use.<br />
It will not be released to third parties unconnected with <strong>the</strong> conference<br />
without your express permission.<br />
For information about <strong>the</strong> exhibition, an updated exhibitor list<br />
or <strong>the</strong> latest update of <strong>the</strong> conference programme, please visit<br />
www.biomedevice-europe.com.<br />
Back Home<br />
17093_FR_BIO11
Change language